The Gray Zone: How 503B Pharmacies Navigate the Intersection of FDA Regulation and Drug Patents
In the complex world of pharmaceuticals, the line between innovation, regulation, and market access is often blurred—creating a “gray zone” that can have profound implications for patients, manufacturers, and the healthcare system at large.
Recently, a…
